MEI Pharma, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical compounds. The company is headquartered in San Diego, California and currently employs 28 full-time employees. The company went IPO on 2003-12-18. The firm's treasury initiative is anchored by Litecoin. The firm has discontinued the clinical development of voruciclib, while certain nonclinical activities related to its drug candidate assets continue to be conducted by it. As part of the review of strategic alternatives, the Company may consider options such as out-licensing opportunities for existing programs and merger and acquisition opportunities.
How did LITS's recent EPS compare to expectations?
The most recent EPS for Lite Strategy Inc is $, expectations of $.
How did Lite Strategy Inc LITS's revenue perform in the last quarter?
Lite Strategy Inc revenue for the last quarter is $
What is the revenue estimate for Lite Strategy Inc?
According to of Wall street analyst, the revenue estimate of Lite Strategy Inc range from $ to $
What's the earning quality score for Lite Strategy Inc?
Lite Strategy Inc has a earning quality score of B+/45.110573. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Lite Strategy Inc report earnings?
Lite Strategy Inc next earnings report is expected in 2026-08-09
What are Lite Strategy Inc's expected earnings?
Lite Strategy Inc expected earnings is $, according to wall-street analysts.
Did Lite Strategy Inc beat earnings expectations?
Lite Strategy Inc recent earnings of $ expectations.